Why is this study being conducted?
This research study is testing a potential new treatment for severe asthma. Asthma is a chronic respiratory disease typically
caused by airway inflammation. Symptoms include wheezing, shortness of breath, chest tightness, and cough, which vary over time and intensity. Asthma patients are treated with multiple medications and have frequent life-threatening exacerbations.
The purpose of this research study is to evaluate the effectiveness and safety of the study drug in participants with a history of asthma exacerbations and severe, uncontrolled asthma.
Who is eligible to participate in this study?
You may be eligible if you:
- Are 18 to 80 years of age
- Have had an asthma diagnosis for more than 2 years
- Have required corticosteroids at least twice over the last 12 months to control your asthma
Applicants who express interest in participating in this study will be reviewed and contacted as other requirement criteria must also be met.
What happens during the study?
Trial duration will be about 2 years and you will have about 13 trial visits.
Trial site visits will occur at the Griffith University Clinical Trial Unit on the Gold Coast.
You will be assigned randomly by chance (like the flip of a coin) to receive the study drug or placebo.
Volunteer to participate
Participation in this study is completely voluntary, and participants can decide to withdraw at any time.
Eligible participants will be reimbursed for their travel associated with each study visit.
Contact Hannah Smith or Taryn Houghton
To learn more about this clinical trial, please contact:
Hannah Smith or Taryn Houghton, Clinical Trial Coordinators.
0479 178 535 clinicaltrialunit@griffith.edu.au
This study has been approved by Bellberry Human Research Ethics Committee #2026-03-440 and GU HREC #2026/0722.
Can't see a trial for you?
Join our volunteer database to be contacted about new clinical trials